Csl behring market cap
WebFind market predictions, CSL financials and market news. ... Market capitalization. 144.798B AUD. Dividends yield (FY) 1.13%. Price to earnings Ratio (TTM) 46.98. Basic … WebToday’s CSL share price, stock chart and announcements. ... CSL's operating model for its two businesses, CSL Behring and Seqirus. Share Price Activity (ASX) Last (Price) Change: 0.00 ... Performance. 1 Week: 1 Month: 2024 YTD: 1 Year: vs Sector (1yr) +2.81% vs ASX 200 (1yr) +17.48% Size. Market Cap Excludes mandatory escrowed shares and ...
Csl behring market cap
Did you know?
WebCSL Behring's parent company, CSL, was formed more than 100 years ago to save lives using the latest technologies. In the century since, CSL Behring has grown into a global biotechnology leader, driven by that same promise to save and improve lives. We offer the broadest range of quality plasma-derived and recombinant therapies in our industry. Web26 rows · Market Capitalization Definition. Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric …
WebOur Products. We specialise in the manufacture of biotherapeutic products, with more than a century of experience in the treatment of various diseases worldwide. In contrast to chemically manufactured pharmaceuticals, biotherapeutic products are manufactured from human plasma or by recombinant processes. We work for patients with coagulation ... WebJan 17, 2024 · In the last year CSL went from fifth to third in the rankings of the world's largest biotechs and its momentum is yet to slow in 2024. ... (market cap $149 billion) as the second most valuable ...
WebMarket Cap $144.8B; Shares Outstanding 482.22M; Public Float 480.65M; Beta 0.90; Rev. per Employee $563.80K; ... It operates through the following segments: CSL Behring … WebApr 12, 2024 · Market cap: 144.86bn AUD: EPS (TTM) 6.58 AUD: Annual div (ADY) 3.46 AUD: Annual div yield (ADY) 1.15%: Div ex-date: Mar 09 2024: ... The Company’s …
WebApr 12, 2024 · CSL Behring either uses plasma-derived proteins or recombinants to treat conditions including immunodeficiencies, bleeding disorders and neurological indications. …
Web24 rows · Market capitalization of CSL (CSL.AX) Market cap: $101.41 … danby ice maker reviewsWebDec 14, 2024 · CSL has offered to acquire Vifor Pharma in an all-cash public tender offer to acquire all publicly held Vifor Pharma shares for US$179.25 per Vifor Pharma share, payable in U.S. dollars. The ... birds recently extinctWebAug 19, 2024 · The Covid-19 pandemic has offered proof of concept for the promise of mRNA vaccines, and now CSL Behring's Seqirus unit wants to take the next step with technology it thinks will drive the field ... birds recording microphoneWebAreas of Expertise. Every day, CSL is reaching for better solutions. Our four areas of focus and exploration—rare and serious diseases (CSL Behring), influenza vaccines (CSL Seqirus), plasma collection (CSL Plasma) and therapies for iron deficiency and nephrology (CSL Vifor)—are leading the way in biotechnology. danby house winston salem north carolinaWebView the latest CSL Ltd. (CSL) stock price, news, historical charts, analyst ratings and financial information from WSJ. danby garage ready chest freezerWebJun 25, 2024 · Market Cap. $1B. Today's Change (-3.75%) -$0.81 ... the company decided to license the rights to its drug to CSL Behring, a leader in hemophilia market share … danby ice maker manualWeb2 days ago · Market Cap $10.77B; Shares Outstanding 51.08M; Public Float 50.68M; Beta 0.96; ... the day after it announced that CSL Behring would acquire exclusive commercialization rights to its gene-therapy ... danby incentives